Funding agencies: U.S. Army Medical Research and Materiel Command (W81XWH-09-0708 and W81XWH-13-1-0025 to J.A.P.); NIH (U01 NS082157 and R01 NS064155 to C.R.S.). The Harvard Biomarker Study is supported by the Harvard NeuroDiscovery Center.
Specific splice variants are associated with Parkinson's disease
Article first published online: 20 SEP 2013
© 2013 Movement Disorder Society
Volume 28, Issue 12, pages 1724–1727, October 2013
How to Cite
Santiago, J. A., Scherzer, C. R., Harvard Biomarker Study and Potashkin, J. A. (2013), Specific splice variants are associated with Parkinson's disease. Mov. Disord., 28: 1724–1727. doi: 10.1002/mds.25635
Relevant conflicts of interest/financial disclosures: Nothing to report.
Full financial disclosures and author roles may be found in the online version of this article.
- Issue published online: 25 OCT 2013
- Article first published online: 20 SEP 2013
- Manuscript Accepted: 14 JUL 2013
- Manuscript Revised: 14 MAY 2013
- Manuscript Received: 22 MAR 2013
This article has been cited by:
- 1Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson’s disease, Proceedings of the National Academy of Sciences, 2015, 112, 7, 2257, ,
- 2A network approach to clinical intervention in neurodegenerative diseases, Trends in Molecular Medicine, 2014, 20, 12, 694, ,